Table 5.

Association results between genetic variants in GAB1 gene, and percentage of EOS and IgE levels

SNVs	Genotypes	EOS (%)	pa	IgE(IU/ml)	pb
rs1396527
	G/G	3.00(1.30–5.60)	0.007	2.08 ± 0.60	0.848
	G/T	5.50(2.50–7.70)		2.14 ± 0.51
	T/T	3.70(2.20–6.70)		2.18 ± 0.46
rs17017425
	T/T	3.10(1.60–6.40)	0.102	2.04 ± 0.50	0.390
	C/T	4.80(2.20–7.60)		2.20 ± 0.58
	C/C	6.80(3.90–8.30)		2.12 ± 0.59
rs1866756
	G/G	3.30(1.60–6.20)	0.136	2.09 ± 0.58	0. 846
	G/A	4.80(2.60–7.18)		2.14 ± 0.50
	A/A	2.40(0.63–11.53)		2.22 ± 0.58
rs3805236
	A/A	3.50(1.60–6.15)	0.309	2.09 ± 0.58	0.877
	A/G	4.45(2.40–7.18)		2.15 ± 0.52
	G/G	4.80(2.50–14.50)		2.10 ± 0.41
rs3805246
	G/G	3.50(1.60–6.48)	0.240	2.10 ± 0.58	0. 064
	G/A	4.80(2.50–6.80)		2.13 ± 0.50
	A/A	2.40(0.63–11.53)		2.22 ± 0.58
rs3805254
	A/A	3.50(1.60–6.48)	0.240	2.10 ± 0.58	0. 064
	A/G	4.80(2.50–6.80)		2.13 ± 0.50
	G/G	2.40(0.63–11.53)		2.22 ± 0.58

The values p < 0.05 were in bold

Abbreviations: ^a Kruskal-Wallis H test for EOS distribution between genotypes in the asthma group; ^b ANOVA for lg (lgE) distribution between genotypes in the asthma group